Suffered harm from Trayslol? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.

The FDA is currently conducting a thorough evaluation of the safety profile for the drug, and is advising healthcare providers carefully weigh the benefits and risks of Trasylol for their patients. The FDA wants physicians to be aware of the following:

- Physicians who use Trasylol should monitor their patients carefully for signs of toxicity, including problems with the kidneys, heart, or central nervous system, and to promptly report any signs of an adverse reaction to Bayer (the drug manufacturer) and/or to the FDA MedWatch program.

- Physicians should limit use of Trasylol to those situations where the clinical benefit of reduced blood loss is essential to the medical management of the patient and outweighs the risks of using the drug.

- The FDA is working with Bayer to evaluate the safety and benefits of Trasylol in light of recent data.

- Patients should discuss all the major risks of undergoing heart bypass surgery with their doctors, including the risks of bleeding and available ways to lessen the Trasylol risk.

Check out the following articles for more information about Trasylol, filing a Trasylol lawsuit and finding a Trasylol attorney.

• Trasylol: Overview


• Trasylol Side Effects


• Trasylol Study, Information and Updates


• Trasylol Lawsuits and Litigation


• Trasylol Attorneys: How to Find and Hire

Suffered harm from Trayslol? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.